Intrinsiqq
Kala Pharmaceuticals, Inc. logo

Kala Pharmaceuticals, Inc. Dividend Analysis

KALA

Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Kala Pharmaceuticals (KALA) pay a dividend?

Kala Pharmaceuticals (KALA) has never paid a dividend. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Kala Pharmaceuticals (KALA) pay a dividend?+

No. Kala Pharmaceuticals (KALA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Kala Pharmaceuticals return cash to shareholders?+

It largely does not. Kala Pharmaceuticals pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Kala Pharmaceuticals afford to pay a dividend?+

Not currently. Kala Pharmaceuticals's free cash flow is negative at -$20 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Kala Pharmaceuticals.

SourceDividend analysis computed from the 10-Q filed 19 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 22 Nov 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Pharmaceutical Preparations · Pick stocks to compare with KALA

CompareIntrinsic value
PRPHProPhase Labs Inc.
$0.01-42.00%0
TRDAEntrada Therapeutics Inc.
$4.35-6.25%10
TXMDTherapeuticsMD, Inc.
$1.71-5.52%29
LPCNLipocine Inc.
$1.50+0.00%40
ATAIAtaiBeckley Inc.
$0.53-25.36%40
CNTBConnect Biopharma Holdings Ltd.
$0.59-6.05%10
MRKRMarker Therapeutics, Inc.
$1.11-15.91%25
PSTVPlus Therapeutics Inc
No recent price20

Spot a number that looks wrong? Check it in KALA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing KALA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.